119-HJRES-167 Journalist Public Summary
A House resolution seeks to overturn the CFPB’s May 12, 2025 rule that withdrew its October 2024 medical‑debt collection advisory; under the Congressional Review Act, disapproving the withdrawal would likely restore those earlier protections. (govinfo.gov)
Headline Summary
Overturns the CFPB’s 2025 withdrawal of its 2024 medical‑debt collection guidance so those consumer protections likely come back into force. (govinfo.gov)
What It Does
This joint resolution uses the Congressional Review Act (CRA) to nullify a CFPB rule issued on May 12, 2025 that withdrew dozens of guidance documents—specifically including the October 4, 2024 advisory opinion on “Deceptive and Unfair Collection of Medical Debt.” If Congress disapproves the withdrawal, CRA practice indicates the prior guidance would generally be reinstated. (govinfo.gov)
In plain English: it aims to bring back the CFPB’s 2024 instructions that said debt collectors can’t misrepresent what patients legally owe, can’t try to collect amounts barred by surprise‑billing laws, and can’t threaten credit‑report harm where it doesn’t apply. (govinfo.gov)
Who’s For It
- House Democratic sponsors focused on consumer protection; a parallel Senate measure (S.J.Res. 141) was introduced by Sen. Raphael Warnock, signaling bicameral support for undoing the CFPB withdrawal. (govinfo.gov)
- Consumer advocates who backed the 2024 medical‑debt advisory, such as the National Consumer Law Center, arguing it curbs deceptive and unfair medical‑debt collection. (library.nclc.org)
Who’s Against It
- Deregulatory policymakers who supported the CFPB’s 2025 withdrawal, which the Bureau justified as reducing compliance burdens and deemphasizing enforcement. (govinfo.gov)
- Republican lawmakers who have opposed CFPB medical‑debt regulations (for example, introducing CRA resolutions to roll back related CFPB rules on medical debt and credit reporting). (rounds.senate.gov)
Why It Matters
For patients, reinstating the 2024 advisory could reduce aggressive or misleading collection tactics on bills that are wrong, already paid, or limited by surprise‑billing protections. For collectors and some providers, it could re‑impose guidance they view as burdensome or beyond the CFPB’s authority. (library.nclc.org)
What’s Next
As of May 1, 2026, the resolution has just been introduced and referred to committee in the House. If it advances, it must pass both chambers; under the CRA, disapproval resolutions get expedited consideration in the Senate before going to the President. (congress.gov)
Discussion